Neurocrine Bioscience buy StockNews.com
Start price
23.09.23
/
50%
€107.85
Target price
23.09.24
-
Performance (%)
-3.38%
End price
24.09.24
€104.20
Summary
This prediction ended on 24.09.24 with a price of €104.20. With a performance of -3.38%, the BUY prediction by StockNews_com finished with a loss. StockNews_com has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -3.057% | -3.057% | 5.700% |
| iShares Core DAX® | -3,51 % | -8,75 % | -1,00 % |
| iShares Nasdaq 100 | -2,78 % | -0,63 % | 14,22 % |
| iShares Nikkei 225® | -2,04 % | -6,84 % | 24,87 % |
| iShares S&P 500 | -2,60 % | -2,23 % | 9,20 % |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Neurocrine Bioscience
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.75
04.08.24
04.08.24
-
04.08.25
04.08.25
-21.11%
05.08.25
05.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.45
27.07.24
27.07.24
-
27.07.25
27.07.25
-16.98%
28.07.25
28.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.65
20.07.24
20.07.24
-
20.07.25
20.07.25
-16.26%
21.07.25
21.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€125.00
21.06.24
21.06.24
-
21.06.25
21.06.25
-11.16%
22.06.25
22.06.25